Wauwatosa, WI, September 3, 2014 --- GE Healthcare (NYSE: GE) today announced the FDA approval of SenoClaire*, GE's new breast tomosynthesis solution designed with a three-dimensional imaging technology. In collaboration with Massachusetts General Hospital, GE developed SenoClaire technology that uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a "step-and-shoot" method, removing the potential motion from the tube helping to reduce blur and increase image sharpness.
ST. LOUIS -- Nuclear medicine scanning will be enriched with the introduction of GE Healthcare's Discovery*^ NM/CT 670 Pro, announced today at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2014). The vision of quantitative accuracy in nuclear medicine is enabled by Q.Metrix^ and Q.AC^, GE Healthcare's newest software innovations in nuclear medicine.
business unit
tags
ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.
business unit
tags
Vienna -- 6th March 2014 -- GE Healthcare, a unit of GE (NYSE: GE), today announced the launch of its 'Dose Blueprint' in Europe at European Congress of Radiology (ECR) in Vienna, a programmatic approach to lowering dose across the entirety of a hospital. The launch coincides with the recently published European Directive which includes specific measures regarding the use of radiation for medical treatments and diagnostics.
business unit
tags
Vienna -- 6th March 2014 -- GE Healthcare, a unit of GE (NYSE: GE), today announced at the European Congress of Radiology (ECR) in Vienna the findings of a new European study showcasing compelling evidence around the value predictive maintenance service software offerings can bring for clinicians, hospitals and patients.
business unit
tags
GE demonstrates the "Power of Partnership" through innovative technologies that improve patient care, comfort and productivity
As the 99th annual meeting of the Radiological Society of North America (#RSNA13) opened today, GE Healthcare, a unit of General Electric Company (NYSE:GE), demonstrated its commitment to delivering innovative healthcare technologies to solve clinicians' most pressing challenges in patient care, comfort and productivity.
business unit
tags
MILWAUKEE - GE Healthcare announced today that its Discovery* PET/CT 690 and PET VCAR 2.0 were used by Professor Patrick Flamen of the Institut Jules Bordet in Brussels in capturing the Society of Nuclear Medicine and Molecular Imaging 2013 "Image of the Year."
Professor Flamen's winning scan illustrated the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease. It was selected as the winning image from more than 2,000 studies.